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O óxido nítrico (•NO) é um antioxidante efetivo na inibição da peroxidação lipídica e circula 
in vivo principalmente como S-nitrosotióis primários (RSNOs). Neste trabalho, a peroxidação in 
vitro de comicelas do ácido linileico-SDS (LA-SDS) catalisada por lipoxigenase de soja (SLO) e 
íons FeII foi monitorada na presença e na ausência de três RSNOs: S-nitrosocisteína, S-nitroso-N-
acetilcisteína e S-nitrosoglutationa. Medidas cinéticas baseadas na formação de duplas ligações 
conjugadas e adutos fluorescentes de lisina-La oxidado mostraram que os RSNOs são antioxidantes 
mais potentes que seus tióis livres (RSHs) correspondentes em condições equimolares. Esses 
resultados são consistentes com o bloqueio da peroxidação de LA-SDS por RSNOs através da 
inativação dos radicais peroxila/alcoxila (LOO•/LO•), levando a produtos nitrogenados do LA 
oxidado, os quais liberam •NO. Esses resultados indicam que os RSNOs endógenos podem 
desempenhar um papel importante no bloqueio da peroxidação lipídica in vivo, através da inativação 
primária de radicais alcoxila/peroxila bem como de hidroperóxidos lipídicos pré-formados.
Nitric oxide (•NO) is an effective chain-breaking antioxidant in the inhibition of lipid 
peroxidation and circulates in vivo mainly as primary S-nitrosothiols (RSNOs). In this work, the in 
vitro peroxidation of linoleic acid-SDS comicelles (LA-SDS) catalyzed by soybean lipoxygenase 
(SLO) and FeII ions was monitored in the presence and absence of three primary RSNOs: 
S-nitrosocysteine, S-nitroso-N-acetylcysteyne and S-nitrosoglutathione. Kinetic measurements 
based on the formation of conjugated double bonds and fluorescent oxidized LA-lysine adducts, 
showed that RSNOs are more potent antioxidants than their corresponding free thiols (RSHs) in 
equimolar conditions. These results are consistent with the blocking of LA-SDS peroxidation 
by RSNOs through the inactivation of peroxyl/alkoxyl (LOO•/LO•) radicals, leading to nitrogen-
containing products of oxidized LA, which release free •NO. These results indicate that endogenous 
RSNOs may play a major role in the blocking of lipid peroxidation in vivo, through the primary 
inactivation of alkoxyl/peroxyl radicals and also of preformed lipid hydroperoxides.
Keywords: nitric oxide, S-nitrosothiols, lipid peroxidation, linoleic acid, lipoxygenase
Introduction 
An increasing amount of evidence has demonstrated 
that oxidative and nitrosative stresses, play a fundamental 
role in atherosclerosis and in other diseases associated with 
lipid peroxidation (LPO).1-6 In these cases, it is assumed 
that free radicals which normally play an essential role in 
metabolic processes, are released from the active site of 
enzymes, triggering a cascade of deleterious effects on 
cells.7 These effects involve the interaction of free radicals 
with metal or organic redox centers and the promotion of 
irreversible oxidation reactions beyond the normal catalytic 
cycles. Once formed, free radicals are also capable of 
initiating other radical reactions, which may become self-
sustaining through the regeneration of propagating radicals 
which are involved in the oxidation of lipids in humans 
representing a key event in the atherosclerotic process. 
This conclusion is reinforced by the fact that both primary 
and secondary lipid oxidation products are found in human 
atherosclerotic lesions.8,9 
Under normal physiological conditions, endothelium-
derived nitric oxide (nitrogen monoxide, •NO) has multiple 
physiological functions in humans, like the regulation of 
vascular tone in both the systemic and renal circulation,10,11 
the prevention of adherence and aggregation of platelets and 
monocytes in the walls of blood vessels12 and the regulation 
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of the proliferation and migration of smooth muscle cells.13 
In addition to the actions related to the mediation of signal 
transduction, via stimulation of guanylate cyclase-mediated 
cGMP synthesis, NO has been shown to exert several 
antiatherogenic properties assigned to its ability to react 
directly with free radicals, blocking the propagation of 
radical reactions. This protective effect has already been 
observed in model lipid systems,14,15 low-density lipoproteins 
(LDL)16-18 and cells19,20 and is supported by several in vitro 
studies which have demonstrated the formation of nitrogen-
containing products of polyunsaturated fatty acids (PUFA), 
including alkylnitrites (RONO), alkylnitrates (ROONO and 
RONO2), alkylepoxynitrite (R(O)NO2), alkylnitrohydroxy 
(RNO2OH), and nitrolipids (RNO2), when PUFAs are 
oxidized in the presence of •NO. Such products have already 
been characterized in other works by mass spectrometry and 
can be taken as markers of the in vivo pro-oxidant and/or 
antioxidant actions of •NO.14,15,21-28 These results stimulate 
new therapeutic approaches for treating lipid peroxidation-
related diseases by enhancing •NO synthesis and/or activity 
by administration of L-arginine and antioxidants.29 As an 
alternative strategy, compounds that act as NO donors could 
be administrated as exogenous NO sources, as already 
demonstrated for the treatment of hepatic steatosis via oral 
administration of the S-nitrosothiol (RSNO) S-nitroso-N-
acetylcysteine (SNAC).3-6 RSNOs are peptides or proteins 
carrying the S-NO moiety and were shown to occur in the 
plasma and cells of mammals where they have the same 
physiological functions of free •NO like vasodilation,30,31 
inhibition of platelet activation and aggregation32,33 and 
post-translational modification of protein function.34,35 
S-nitrosoglutathione (GSNO), S-nitrosoalbumin and 
S-nitrosohemoglobin, for example, have been considered 
to be •NO carriers and donors in humans and are the focus 
of several studies both in vivo and in vitro.36 Other RSNOs, 
like S-nitrosocysteine (CySNO) have also been described.37 
What classifies a RSNO as primary is the fact that the 
sulfur atom of its SNO moiety is bound to a primary carbon 
atom (Figure 1), while in S-nitroso-N-acetylpenicillamine 
(SNAP), which is widely used in experimental studies, the 
sulfur atom is bound to a tertiary carbon atom, making it a 
“tertiary” RSNO. Evaluating the antioxidant properties of 
primary RSNOs may have an additional relevance, once 
the lability of •NO in primary and tertiary RSNOs can be 
different.37-39 In any case, one of the important characteristics 
of having •NO carried as RSNOs is its preservation from 
inactivation caused by reaction with oxygen, leading to nitrite 
(NO2–) and further to nitrate (NO3–),40 two of the main end 
products of •NO metabolism. Although several exogenous 
•NO sources (which are not found endogenously) have been 
used as antioxidants in LPO studies like organic nitrites and 
NONOates,41 only one work has reported the protective role 
of primary RSNOs in blocking LPO reactions.42
In this work, the in vitro peroxidation of linoleic acid SDS 
comicelles (LA-SDS) catalyzed by soybean lipoxygenase 
(SLO) and by FeII ions was monitored in the presence and 
absence of three primary RSNOs: CySNO, SNAC and GSNO 
and of their corresponding free thiols (RSHs), at 37 ºC. Kinetic 
data showed that RSNOs can block LA peroxidation much 
more efficiently than RSHs, by inactivating alkoxyl/peroxyl 
(LO•/LOO•) radicals and LA hydroperoxides, (LOOH = 
13-hydroperoxy-octadecadienoic acid, 13-HPODE) through 
nitration and transnitrosation reactions. These results suggest 
that endogenous primary RSNOs may play a major role in 
blocking lipid peroxidation in vivo.
Experimental
Reagents
Ascorbic acid, cysteine (CySH), ferrous sulfate 
(FeSO4), copper sulfate (CuSO4), glutathione (g-Glu-Cys-
Glu, GSH), linoleic acid (LA), L-lysine monohydrochloride 
(Lys), malonaldehyde bis(dimethyl acetal) (MDA), 
N-acetyl-L-cysteine (NAC), phosphate buffer saline (PBS, 
pH 7.4), sodium dodecil sulfate (SDS), sodium nitrite 
(NaNO2), soybean lipoxygenase (SLO), hydrochoric acid 
(HCl), mercury chloride (HgCl2), tert-butyl hydroperoxide 
(tBOOH, C4 H10 O2) (Sigma/Aldrich, St. Louis, MO) and 
sulfanilamide (Merck, Germay), were used as received. All 
the experiments were carried out using analytical grade 
water from a Millipore Milli-Q gradient filtration system.
Figure 1. Molecular structures of S-nitroso-L-cysteine (CySNO), S-nitroso-N-acetylcysteine (SNAC) and S-nitrosoglutathione (GSNO).
Simplicio et al. 1887Vol. 21, No. 10, 2010
Synthesis of GSNO, CySNO and SNAC in aqueous solution
Aqueous GSNO solution was prepared by the reaction 
of GSH with sodium nitrite in acidic medium as described 
elsewhere.37,43 GSNO was obtained as stable reddish 
crystals in the pure form and was dried by freeze-drying. 
Freshly prepared GSNO solutions in PBS were used in 
the experiments. S-nitroso-N-acetylcysteine (SNAC) and 
S-nitrosocysteine (CySNO) cannot be precipitated from 
solution and stored as dry solids because of their high 
solubility in water. Therefore, aqueous SNAC or CySNO 
solutions were synthesized through the equimolar reaction of 
NAC or CyS, respectively, with NaNO2 in acidified aqueous 
solution. Stock acidic SNAC and CySNO solutions freshly 
prepared, were diluted in PBS and used immediately.
Characterization of linoleic acid peroxidation
Linoleic acid (LA) peroxidation was induced through 
the addition of SLO to aqueous LA dispersions (final 
concentration 19 mmol L-1) in SDS solution (0.01 mol L-1) 
(LA-SDS comicelles). Each LA dispersion was transferred 
to a quartz cuvette, blowed with O2 for 2 min and SLO (final 
concentration 56 nmol L-1) was added to the cuvette with 
a syringe to start the peroxidation reaction. Peroxidation 
reactions were monitored in the absence or presence of CySH, 
NAC and GSH (final concentrations 560 mmol L-1) and of 
their corresponding RSNOs, CySNO, SNAC and GSNO, 
respectively (final concentrations 56 mmol L-1), through the 
increase in absorbance at 234 nm, due to conjugated diene 
formation. A Hewlett Packard spectrophotometer, model 
8453 (Palo Alto, CA, USA) with a temperature-controlled 
cuvette holder was used to monitor the spectral changes in 
the range 200-600 nm in the dark at 37 °C, in time intervals 
of 2 s. Spectra of the solutions were obtained in 1 cm quartz 
cuvette, under stirring (1,000 r min-1). Each point in the 
kinetic curves of absorbance vs. time is the average of two 
experiments with error bars expressed by their standard 
errors of the mean (SEM). Statistical differences among the 
initial rates (I
r
) of LA peroxidation, catalyzed by SLO, in 
the absence and presence of RSHs and their corresponding 
RSNOs were evaluated using ANOVA followed by Tukey-
Kramer multiple test.
Characterization of fluorescent MDA-lysine adduct
To characterize the emission spectrum of the fluorescent 
adduct formed in the reaction of oxidized linoleic acid 
(oxLA) and lysine, an MDA-lysine adduct was prepared 
as a model adduct by reacting MDA with L-lysine in 
equimolar condition (final concentration 0.25 mol L-1) 
in PBS solution at room temperature and the emission 
spectrum was obtained in the range 375-600 nm, with 
excitation wavelength of 360 nm.
Spectrofluorimetric characterization and monitoring of 
oxidized LA-lysine adduct formation
LA peroxidation was induced through the addition of 
aqueous FeSO4 solution (final concentration 5.0 µmol L-1) to 
aqueous LA (final concentration 1.2 mmol L-1) dispersions 
in SDS solution (final concentration 0.01 mol L-1) in the 
absence or presence of GSNO (final concentrations 5 and 
500 mmol L-1) for 2 h in PBS (pH 7.4). After LA oxidation, 
lysine solution (final concentration 1.0 mmol L-1) was 
transferred to the dispersions followed by incubation for 
48 h. The kinetics of formation of fluorescent oxidized 
LA-lysine adduct (oxLA-Lys) in the reaction between 
oxLA and Lys during the incubation time was characterized 
based on the spectral changes in the range 375 to 600 nm 
and on the emission intensity at 430 nm, under excitation 
at 360 nm. All the spectrofluorimetric measurements were 
performed using a Perkin-Elmer LS55 spectrofluorimeter 
with a temperature-controlled cuvette holder at 37 ºC.
Infrared characterization of linoleic acid peroxidation
Linoleic acid peroxidation was induced by heating 
a sample of pure LA at 80 ºC for 4 h under stirring in a 
glass flask with O2 atmosphere, obtained by continuously 
blowing O2 from a cylinder into the headspace of the flask. 
Aliquots of LA were removed from the reaction flask 2 
and 4 h after the beginning of the peroxidation reaction. 
Capillary films of non-oxidized and peroxidized LA were 
obtained between two calcium fluoride (CaF2) windows, 
which were mounted in special sample holder. IR spectra 
were obtained in the range 4000-1000 cm-1 using an FTIR 
Bomem MB-series, model B-100. An IR spectrum of non-
oxidized LA was obtained as a control.
Detection of •NO released from nitrogen-containing 
products of oxidized LA
Nitric oxide released from nitrogen-containing 
products of oxLA formed in the peroxidation of LA 
in the presence of GSNO, was detected using a gas-
phase chemiluminescence-based nitric oxide analyzer 
(NOA, Sievers, Bolder Co, USA). Peroxidation of 
LA was induced by two different procedures. In the 
first, the LA-SDS dispersion in the presence of CuII 
(900 mmol L-1) ions was previously blowed with O2 for 
2 min, followed by incubation with GSNO (900 mmol L-1) 
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for 30 min at room temperature. In the second, 
peroxidation of LA was induced by heating a sample of 
pure LA at 80 ºC for 1 h under stirring in a glass flask with 
O2 atmosphere, obtained by continuously blowing O2 from 
a cylinder into the headspace of the flask. After oxidation, 
oxLA was dispersed in SDS solution (0.01 mol L-1) and 
incubated with GSNO, for 30 min at room temperature. 
In both cases, after incubation, non-reacted excess 
GSNO was removed from the solution by adding HgCl2 
(final concentration 29.4 mmol L-1) and allowing GSNO 
decomposition to GS-SG and free •NO to proceed for 
15 min. In this condition, •NO is quantitatively released 
from excess GSNO by mercuric catalysis and is rapidly 
and quantitatively converted to its stable end product, 
nitrite (NO2–). Nitrite formed was removed by adding a 
10% v/v solution of sulfanilamide (6.0 mmol L-1 in HCl 
2 mol L-1), followed by incubation for 15 min. A volume 
of 5 mL of aqueous saturated ascorbic acid solution, used 
as a reducing agent, was added in the glass purge vessel 
of the NOA. Antifoaming agent was used to prevent 
foaming caused by injection of the samples. Volumes 
of 100 mL of the final nitrogen-containing products 
of oxLA suspension were injected in the glass purge 
vessel containing ascorbic acid, through an impermeable 
septum. Nitrogen gas (Air Liquid, Brazil) was bubbled 
through the solution and free •NO formed due to the 
reduction of nitrogen-containing products of oxLA by 
ascorbic acid in the glass purge vessel was carried into 
the reaction chamber for detection. Control curves are 
for the measurements of samples of water incubated with 
GSNO 900 mmol L-1 without LA-SDS and CuII for 30 min 
at room temperature (control 1), and of water incubated 
with GSNO 900 mmol L-1 and CuII without LA-SDS for 
30 min at room temperature (control 2). In both cases, 
the incubations were followed by the addition of HgCl2 
(final concentration 29.4 mmol L-1) for promoting GSNO 
decomposition to GS-SG and free •NO for 15 min and 
by the addition of a 10% v/v solution of sulfanilamide 
(6.0 mmol L-1 in HCl 2 mol L-1), for 15 min for eliminating 
nitritre formed in the reaction between NO and O2.
Reaction between RSNOs and tert-butyl hydroperoxide
The formation of tert-butyl peroxynitrites (tBOONOs) 
in the reactions between tert-butyl hydroperoxide 
(tBOOH) and RSNOs was characterized by following 
the decomposition of GSNO, SNAC and CySNO (initial 
concentrations 1 mmol L-1) upon the addiction of tBOOH 
(initial concentration 25 mmol L-1) in basic medium 
(pH 12). The decomposition of RSNOs in absence or 
presence of tBOOH was characterized by following 
the spectral changes of RSNOs solutions in the range 
220-1100 nm in the dark, in a 1 cm quartz cuvette 
referenced against air. Kinetic curves of GSNO, SNAC and 
CySNO decomposition were obtained from the absorption 
changes at 336 nm in time intervals of 15 s, at 37 ºC, for 
8 min. The control experiment was performed by incubating 
RSNOs with pure water at pH 12, adjusted with NaOH 
solution. Each point in the kinetic curves of concentration 
vs. time is the average of two experiments with error bars 
expressed by their standard errors of the mean (SEM).
Results and Discussion
Kinetic characterization of linoleic acid peroxidation
Figure 2 shows the kinetic curves corresponding to 
the spectral changes monitored at 234 nm in the first 
80 s of LA oxidation by SLO in the presence of RSHs 
and RSNOs. The band at 234 nm is associated with the 
formation of conjugated double bonds in LA, as a result 
of LA peroxidation.35 In this time range, the curves reach 
an apparent plateau after ca. 20 s in all cases. The initial 
rates of reaction (I
r
), as well as the height of the plateaus, 
are decrease significantly in the presence of RSHs and 
RSNOs, compared to the peroxidation of LA alone. As 
the height of the plateaus can be taken as a measurement 
of the extent of the peroxidation reaction in its initial 
phase, this result indicates that RSNOs in concentrations 
ten times lower than their corresponding RSHs (56 versus 
560 mmol L-1) exert a much more extensive blockage of 
the peroxidation reaction than the corresponding RSHs 
in this time range. 
The initial rates of LA peroxidation (I
r
), extracted 
from the curves of Figure 2 are shown in the bar graphs of 
Figure 3 for comparison. It can be seen that the I
r
 of LA 
(19 mmol L-1) peroxidation is decreased to about ½ of the 
control value in the presence of RSHs (560 mmol L-1), 
i.e., at a molar ratio RSH/LA = 29.5, with no significant 
differences among the antioxidant actions of CySH, 
NAC and GSH. In contrast, the presence of RSNOs at a 
concentration ten times lower (56 mmol L-1), i.e., at a molar 
ratio RSH/LA = 2.9 reduced I
r
 values to ca. 1/5 of the 
control value, also with no significant differences among 
the action of CysNO, SNAC and GSNO. 
Fluorimetric characterization and monitoring of oxidized 
LA-lysine adduct formation 
Figure 4 shows the emission spectra obtained after 
LA oxidation catalyzed by FeII ions for 2 h, followed 
by incubation of the solution with lysine for 48 h at 
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37 ºC. The peroxidation reactions were performed in 
the absence (a) and presence of GSNO 5.0 mmol L-1 (b) 
and 500.0 mmol L-1 (c). The inset in Figure 4 shows the 
emission spectrum obtained after the incubation of MDA 
with lysine in equimolar concentrations of 0.25 mol L-1, 
as a control experiment. Figure 5 shows the kinetic curves 
of the fluorescent oxLA-lysine adduct formation in the 
reaction between oxidized LA and lysine in conditions 
(a), (b) and (c) of Figure 4. The curves were based on the 
spectral changes monitored at 430 nm, during 48 h after 
lysine addition. It can be observed that the formation of 
the oxLA-Lys adduct follows a sigmoid pattern with an 
apparent induction or “lag” phase, which is evident in 
curves (a) and (b). In curve (c) the reaction is still in an 
apparent lag phase until 48 h of monitoring, although a 
small rate of fluorophore formation can be detected since 
the beginning of the reaction.
Figure 2. Kinetic curves of LA (19 mmol L-1) peroxidation catalyzed by 
(SLO) (56 nmol L-1), in the absence of RSH or RSNO (Control, A) and 
in the presence of CySH 560 mmol L-1 and CySNO 56 mmol L-1 (A); 
NAC 560 mmol L-1 and SNAC 56 mmol L-1 (B) and GSH 560 mmol L-1 
and GSNO 56 mmol L-1 (C). Absorbance changes were monitored at 
234 nm at 37 ºC. 
Figure 3. Initial rates (I
r
) achieved after ca. 20 s of LA peroxidation, 
catalyzed by SLO, in the absence and presence of RSHs and 
their corresponding RSNOs at concentrations ten times lower. 
[LA] = 19 mmol L-1; [SLO] = 56 nmol L-1; [RSHs] = 560 mmol L-1 
and [RSNOs] = 56 mmol L-1. Data extracted from the kinetic curves of 
Figure 2. * p < 0.001; ** p < 0.05.
Figure 4. Emission spectra obtained after linoleic acid (LA) oxidation 
(final concentration 1.2 mmol L-1) catalyzed by FeII ions (FeSO4, final 
concentration 5.0 mmol L-1) for 2 h, followed by incubation of the solution 
with lysine (Lys) (final concentration 1.0 mmol L-1) for 48 h at 37 ºC in the 
absence (a) and presence of GSNO 5.0 mmol L-1 (b) and 500.0 mmol L-1 
(c). Excitation/emission wavelengths 360/430 nm. Inset: Emission spectra 
of MDA incubated with Lys in equimolar concentrations of 0.25 mol L-1, 
used as a control.
Figure 5. Kinetic curves of fluorescent oxidized LA-Lys adduct formation 
during the reaction between oxidized LA and Lys in the conditions (a), (b) 
and (c) of Figure 4, based on the spectral changes monitored at 430 nm 
during 48 h, after Lys addition.
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Detection of LA peroxidation by infrared spectroscopy 
Figure 6 shows the spectral change in the normal 
infrared region, obtained after 2 and 4 h of heating of pure 
LA at 80 ºC under O2 atmosphere. The new absorption 
band with maximum at ca. 1180 cm-1 can be assigned to 
the C–O–O vibration of hydroperoxides (LOOH).45
Detection of •NO released from nitrogen-containing 
products of oxidized LA
Figure 7 shows the peaks of light emission obtained 
in the chemiluminescence reaction of free •NO, released 
from nitrogen-containing products of oxLA, formed in 
the reaction between oxLA and GSNO. The two peaks 
shown were obtained after reduction of nitrogen-containing 
products of oxLA by ascorbate, according to the procedures 
described above. Peak (a) was obtained in the reduction of 
a sample of LA-SDS dispersion oxidized in the presence 
of CuII ions and GSNO. The same result was observed 
when SNAC or CySNO were used in the place of GSNO 
(data not shown). Peak (b) was obtained in the reduction 
of a sample of LA-SDS dispersion incubated with GSNO, 
where pure LA had been previously oxidized by heating 
under O2 at 80 °C. The detection of free •NO in these cases 
shows that nitrogen-containing products of oxLA are 
formed either when LA is oxidized in aqueous dispersion 
in the presence of GSNO or when a dispersion of oxLA-
SDS is subsequently incubated with GSNO. Control curves 
are for the measurements of samples of water incubated 
with GSNO without LA-SDS and CuII (control 1), and of 
water incubated with GSNO and CuII without LA-SDS 
(control 2), which show that GSNO was completely 
eliminated through decomposition by HgII ions, followed 
by NO2– trapping by sulfanilamide, before injection in the 
ascorbic acid soluti
Reaction between RSNOs and tert-butyl hydroperoxide
Figure 8 shows the kinetic curves corresponding to 
the spectral changes due the disappearance of the RSNOs, 
CySNO, SNAC and GSNO, during their reaction with tert-
butyl hydroperoxide (tBOOH) with formation of tert-butyl 
peroxynitrites (tBOONOs). Control curves correspond to 
the monitoring of RSNOs solutions at the same temperature 
and pH conditions, but in the absence of tBOOH. It can 
be seen that the RSNOs solutions are quite stable in the 
absence of tBOOH and that their thermal decompositions 
are negligible in this time range. On the other hand, the 
presence of tBOOH leads to the fast disappearance of 
the absorption bands of the three RSNOs, indicating that 
they react with tBOOH. The rates of reaction of SNAC 
and GSNO are very similar and follow pseudo-first order 
kinetics. However, CySNO shows a different kinetic 
pattern, with an apparent bimodal behaviour. In this case, 
the rate of reaction is lower and approximately constant up 
to ca. 3 min and increases after this time, becoming similar 
to the rates observed in the last 4 min for SNAC and GSNO. 
In the lipid pool of plasma and cells, polyunsaturated 
fatty acids (PUFAs) have higher propensity to oxidation due 
to the fact that bis-allylic methylene hydrogens are more 
Figure 6. Infrared spectral changes associated with the formation of 
hydroperoxides in the oxidation of linoleic acid at 80 ºC under O2 
atmosphere for 2 and 4 h.
Figure 7. Light emission peaks obtained in the chemiluminescence 
reaction of ozone with free NO, released in the reduction of nitrogen-
containing products of oxidized linoleic acid (oxLA) formed in the 
peroxidation reaction of LA in the presence of GSNO (900 µmol L-1). 
For details see experimental part. Peak (a) was obtained for the product 
formed after the incubation of LA with CuII ions (900 µmol L-1) in the 
presence of GSNO. Peak (b) was obtained for the product formed after the 
incubation of LA previously oxidized by heating under O2 with GSNO. 
Control curves are for the measurements of samples of water incubated 
with GSNO without LA-SDS and CuII (control 1), and of water incubated 
with GSNO and CuII without LA-SDS (control 2).
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susceptible to hydrogen abstraction by oxidizing radicals 
than the methylene hydrogens from fully saturated lipids.44 
After such initiation process, the rapid reaction between the 
formed carbon-centered radical and dioxygen (O2) forms 
a lipid peroxyl radical (LOO•). Propagation occurs via the 
reaction between LOO• and intact fatty acid (LH) molecules 
forming lipid hydroperoxides (LOOH), which leads to the 
formation of more LOO• species through the decomposition 
of LOOH catalyzed by CuII or FeIII ions either free or in the 
form of heme proteins.46-48 In addition, LOOH can lead to 
the formation of alkoxyl radicals mediated by FeII. These 
processes are represented in Scheme 1.
Linoleic acid (LA), one of the components of LDL 
particles, is a major unsatured fatty acid in the american 
diet and is considered to be atherogenic because of its 
pro-oxidative and pro-inflammatory response through the 
activation of endothelial cells.49,50 An increase in LA levels 
has been reported in the phospholipid fractions of human 
coronary arteries in cases of sudden cardiac death due to 
ischemic heart disease.51 Additionally, concentrations of 
LA in adipose tissue were positively correlated with the 
degree of coronary disease.52 Linoleic acid has a double 
bond configuration with bis-allylic methylene hydrogens 
(Scheme 1). Due to this characteristic, and due to the 
reasons mentioned above, LA is an appropriate model 
compound for LPO studies. The kinetic monitoring of 
conjugated double bond formation in LA-SDS comicelles 
catalyzed by SLO (Figure 2) shows that LA is effectively 
oxidized in aqueous dispersion by dissolved O2. It must be 
considered that, in this particular condition, SLO is also 
an appropriate catalyzer as a member of a well known 
group of enzymes able to induce enzymatic peroxidation 
of polyunsaturated fatty acids in biological membranes 
and lipoproteins.53,54 In general, such enzymes contain 
an essential iron atom, which is present as FeII in the 
inactive enzyme form; enzymatic activation occurs through 
hydroperoxide-driven oxidation of FeII to FeIII. 
Although the kinetics of lipoperoxidation induced by 
SLO, CuII and FeII ions may be different, the formation 
of alkoxyl and peroxyl radicals is a common result in 
all cases, since hydrogen abstraction by any initiator in 
the presence of O2 will lead to the formation of these 
propagating species. The results of all experiments herein 
presented are in accordance with the inactivation of alkoxyl 
and peroxyl species by the RSNOs. The expected products 
in all cases are LOONO and LONO species. In fact, 
nitrated lipid formation have been shown to occur in vivo 
as potential “footprint” of the critical role that •NO and/or 
•NO-derived reactive species play during lipid oxidation 
processes.8 The RSNOs used here cannot be considered 
classical antioxidants like a-tocopherol (a-TOH) or 
ascorbic acid. Although a-TOH reacts with LOO• forming 
a tocopheroxyl radical (a-TO•) which can scavenge another 
LOO• species, allowing two LOO• radicals to be scavenged 
by one a-TOH molecule, the primary product of this 
reaction is LOOH and its accumulation may expose lipids 
to subsequent oxidation mediated by metal ions.48 A similar 
process can be described for other classical antioxidants 
found in cells, like ascorbic acid and glutathione (GSH). 
Figure 8. Kinetic curves corresponding to the spectral changes of 
CySNO, SNAC and GSNO (initial concentration 1.0 mmolL-1) solutions 
in the presence and absence of tBOOH (final concentration 25 mmol L-1), 
monitored at 336 nm for 8 min, at 37 ºC. Control curves correspond to 
the thermal decomposition of RSNOs solutions in the same temperature 
and pH conditions but in the absence of tBOOH.
Scheme 1. Formation of lipid fluorescent oxidized LA-lysine adducts.
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Both are highly susceptible to hydrogen abstraction, 
generating ascorbyl and thyil radicals and leading to LOOH 
formation in their primary reactions. In the case of GSH, the 
fate of the glutathionyl radical (GS•) formed is dimerization, 
forming oxidized glutathione (GS-SG), the ration 
GSH/GS-SG being a well-known marker of oxidative 
stress.55 The protective actions of RSNOs are primarily 
linked to the well-known antioxidant action of •NO as 
a radical-chain terminator, which arises from the fact 
that •NO is itself a free radical. Like its reaction with 
superoxide (O2•–) generating peroxynitrite (ONOO–, 
k = 6.7 × 109 L mol-1 s-1)56 free •NO may react extremely 
fast with LOO• (k = 2 × 109 L mol-1 s-1)48 removing this 
chain carrying radical from the reaction scene. Although 
formation of ONOO– is usually associated with a pro-
oxidant response reflected also in the nitration of tyrosine 
residues,48,57 the deleterious actions of ONOO– have been 
shown to depend strongly on the balance between •NO and 
O2•–.48 More generally, the balance between oxidant species 
and •NO seems to be fundamental in allowing a protective 
action of •NO against LPO. Hummel et al.20 for example, 
have shown that quite low levels of •NO (ca. 50 nmol L-1) 
are enough to suppress FeII-O2 lipid oxidation in vitro in 
cell models.
Although aqueous RSNOs solutions may spontaneous 
release free •NO in vitro through the homolytic cleavage 
of the S–N bond, the chemical stability of RSNOs 
solutions at low concentrations is high enough to allow 
these compounds to react directly with other substrates 
in a bimolecular mechanism. The decomposition of 
RSNOs with NO release may occur in several hours and 
days, depending on the experimental condition.19 In the 
present work, as shown in Figure 2, the kinetic curves 
of LA peroxidation were monitored for only 80 s. In this 
time frame RSNOs are stable and the inhibition of lipid 
peroxidation can be assigned to the primary reactions 
between intact RSNOs molecules and oxyl/peroxyl species.
In the case of LA peroxidation, the primary reaction 
of RSNOs with LO• or LOO• species will lead to the 
formation of LOONO or LONO species and not to LOOH 
or LOH species, as in the case of hydrogen abstraction from 
classical antioxidants.
As a complementary analysis of the protective action 
of RSNOs in LPO, one may also consider that linoleate 
hydroperoxide (LOOH) formed as a primary oxidation 
product of LA is expected to undergo b-scission generating 
free aldehydes. It is generally assumed that adducts formed 
in the conjugation of free aldehydes generated during 
peroxidation of PUFAs with amino groups on LDL particles 
are proteins with Schiff bases (containing the -C=N- group). 
Formation of such adducts is central in the atherosclerotic 
process once it neutralizes the cluster of positive charges 
on the surface of LDL particles, conferring to them a 
higher anionic electrophoretic mobility and a reduced 
recognition by the LDL receptor on fibroblasts, while 
increasing their recognition by macrophages.60 As Schiff 
bases have fluorescence properties,61,62 it was assumed in 
this work that such adducts could be used to characterize 
the formation of aldehydes from hydroperoxides in the 
peroxidation of LA. It was found here that the fluorescence 
emission spectra obtained after LA oxidation catalyzed by 
FeII ions followed by incubation of the solution with Lys, 
has exactly the same shape and position of the spectrum 
obtained in the incubation of MDA with Lys (Figure 4). 
This result shows that products of LA peroxidation are 
also reactive toward lysine, forming the same fluorescent 
Schiff base adduct formed in oxidized LDL (like the MDA-
lysine adduct). The fluorescent adduct identified in this 
work was assigned to the reaction between the aldehydes 
formed from the reduction and b-scission of LOOH, with 
lysine (Scheme 2). More specifically, the reaction involves 
the nucleophilic addition between the amino group of 
lysine and the carbonyl group of the aldehydes, forming 
hemiaminals, followed by dehydration to generate stable 
imines. In Scheme 2, these reactions are represented for 
the two possible aldehydic fragments of LOOH b-scission: 
12-oxododecanoic acid and hexanal. Of course, in different 
oxidative situations several other aldehydic products may 
form after LA peroxidation, which may also generate 
fluorescent adducts with lysine. In addition to the aldehyde-
type lysine adducts, amide-type-lysine adducts have also 
been described by Kawai and co-workers63,64 as a new class 
of protein adducts derived from lipid peroxidation. 
The dose-dependent reduction in the amounts of 
aldehyde-type lysine adducts formed in the presence 
of GSNO 5.0 µmol L-1 and 500.0 µmol L-1 in Figure 4, 
compared to the peroxidation reaction performed in the 
absence of GSNO, reflect the protective effect of GSNO in 
this particular peroxidation condition. This protective action 
is also reflected in the reduction of the rates and increase in 
the apparent lag phase of the aldehyde-type lysine adducts 
formation (Figure 5). 
The formation of nitrogen-containing products of oxLA, 
induced by CuII ions and heat, during the peroxidation of 
LA in the presence of RSNOs was demonstrated in the 
present work by reducing these products to free •NO and 
hydroperoxides with ascorbic acid, according to procedures 
already described in other works.14 The reaction involved 
can be written as:
2 LOONO/LONO + AscH– + H+ →
	 2LOOH/LOH + DHA + 2 •NO     (1)
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where AscH– is the ascorbate anion and DHA is 
dehydroascorbic acid formed in the oxidation (hydrogen 
abstraction) of AscH–. Free •NO released in this reaction 
was unequivocally detected by chemiluminescence, after 
its removal from the solution by bubbling with N2 and its 
reaction with ozone (O3). It must be emphasized here that 
to avoid any possible interference of •NO released from 
excess GSNO, instead of •NO released from nitrated LA, 
excess GSNO (which did not reacted with LOO•) was 
completely eliminated from the solution by addition of HgII 
ions and sulfanilamide. It is know that •NO is quantitatively 
liberated from GSNO• by mercuric catalysis, and it is 
rapidly and quantitatively converted to its stable solution 
end-product, nitrite (NO2–) in aerated medium. By adding 
sulfanilamide to the solution, NO2– formed is completely 
removed, and therefore the •NO signal detected in this 
analysis can be attributed solely to •NO released from 
nitrogen-containing products of oxLA. This conclusion is 
supported by the control experiments, which confirmed that 
GSNO is completely eliminated by the mercuric catalysis/
sulfanilamide procedure. In addition, it was observed 
that RSNOs react with LA previously oxidized through 
heating, once incubation of oxLA-SDC comicelles with 
GSNOs, led also to the formation of nitrogen-containing 
products of oxLA, detected by their reduction to •NO with 
ascorbate. This result points to the ability of RSNOs to 
inactivate preformed LA hydroperoxides (LOOH). In this 
case, the bimolecular reaction is expected to proceed via a 
transnitrosation mechanism and can be written as:
LOOH + RSNO → LOONO + RSH  (2)
It must be noted that the formation of LOOH in the 
LA oxidized by heating under O2 was proven by observing 
the appearance of an IR absorption band with maximum 
around 1180 cm-1, assigned to the C-O-O vibration of 
hydroperoxides (LOOH).45 The reactivity of RSNOs against 
tert-butyl hydroperoxide (tBOOH) is an additional evidence 
for reaction 2. Although the different kinetic behavior of 
CysNO compared to SNAC and GSNO in Figure 8 is not 
reflected in the initial rates of LA peroxidation in Figure 3, it 
must be noted that reaction rates in Figure 3 were calculated 
over the first 20 s of reaction, while differences in the 
kinetic behavior among the three RSNOs in Figure 8 begin 
to appear after 60 s. In addition, reaction rates in Figure 3 
reflect not only the inactivation of LOOH by RSNOs but 
mainly of LO• and LOO• species. Therefore, the evidences 
of the ability of primary RSNOs to block the propagation of 
Scheme 2. Key sites of primary S-nitrosothiol action on pathways of linoleic acid peroxidation.
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lipid peroxidation reaction not only by inactivating LO• or 
LOO• radicals, but also by inactivating preformed LOOH, 
reinforces the potential role of endogenous RSNOs as 
modulators of peroxidation reactions in vivo. The relevance 
of this evidence can be better appreciated by considering 
that the reduction of LOOH to LO• radical by metal ions as 
FeII or CuII represents an important via for the propagation of 
radical reactions in the lipid peroxidation process. Although 
SLO, FeII and CuII have chemical peculiarities, it might be 
consider that the three compounds lead to the formation of 
nitrogen containing products of oxLA,8 which can release 
NO upon reduction with ascorbic acid. For example, it has 
been reported that lipid peroxidation of LA by lipoxygenase 
yielded nitrogen-containing lipid derivatives.8
Thus, if the role of endogenous •NO as an antioxidant 
species is linked in vivo to its presence in primary RSNOs, 
this role must be extended beyond its classical radical 
chain termination action, to encompass the inactivation 
of deleterious hydroperoxides also present in the cellular 
milieu. These multiple protective actions of RSNOs are 
summarized in Scheme 1 for the case of LA peroxidation 
and can be generalized for other lipids. These results 
raise the possibility that primary RSNOs are involved in 
the formation of nitrogen-containing lipids (and perhaps 
of nitroalkanes), which all may be natural membrane 
components and may have biological activities intimately 
linked with the biological activities of RSNOs.
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